One limitation of this study is that we modeled sumatriptan-induced sensitization and its resolution by LD-IL-2 in mice that have not been repeatedly exposed to triggers of primary headache, whereas MOH patients usually have a long history of migraine or tension-type headache [1, 2]. Here, IL2 is linked to migraine disorder.